S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Actavis Confirms Generic Neupro® Patent Challenge|
|UCB and Dermira enter into strategic collaboration in dermatology to broaden patient access to Cimzia® (certolizumab pegol) (2014/7/3)|
|Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2014 Financial Results|
|Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting|
|Data Published in the New England Journal of Medicine Demonstrate that Naloxegol Improved Opioid-Induced Constipation in Chronic Pain Patients|
|MiMedx Expects To File Its First Investigational New Drug Application In July|
|TransCelerate Selects Cognizant to Develop a Clinical Trials Collaboration Platform|
|Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets|
|East West Bancorp Reports Net Income for Second Quarter of 2014 of $84.0 Million, Up 13% from Prior Year and $0.58 Per Diluted Share, Up 12% from Prior Year|
|Five Prime Therapeutics Announces Second Quarter 2014 Financial Results|
Click above to view more mutual fund data and stats for ucb - UCB SA.